Global Skin Disease Morbidity and Mortality

Importance Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin diseases. Objective To measure the burden of skin diseases worldwide. Data Sources For nonfatal estimates, data were found by literature search using PubMed and Google Scholar in English and Spanish for years 1980 through 2013 and by accessing administrative data on hospital inpatient and outpatient episodes. Data for fatal estimates were based on vital registration and verbal autopsy data. Study Selection Skin disease data were extracted from more than 4000 sources including systematic reviews, surveys, population-based disease registries, hospital inpatient data, outpatient data, cohort studies, and autopsy data. Data metrics included incidence, prevalence, remission, duration, severity, deaths, and mortality risk. Data Extraction and Synthesis Data were extracted by age, time period, case definitions, and other study characteristics. Data points were modeled with Bayesian meta-regression to generate estimates of morbidity and mortality metrics for skin diseases. All estimates were made with 95% uncertainty intervals. Main Outcomes and Measures Disability-adjusted life years (DALYs), years lived with disability, and years of life lost from 15 skin conditions in 188 countries. Results Skin conditions contributed 1.79% to the global burden of disease measured in DALYs from 306 diseases and injuries in 2013. Individual skin diseases varied in size from 0.38% of total burden for dermatitis (atopic, contact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.19% for urticaria, 0.16% for viral skin diseases, 0.15% for fungal skin diseases, 0.07% for scabies, 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte carcinoma, 0.03% for decubitus ulcer, and 0.01% for alopecia areata. All other skin and subcutaneous diseases composed 0.12% of total DALYs. Conclusions and Relevance Skin and subcutaneous diseases were the 18th leading cause of global DALYs in Global Burden of Disease 2013. Excluding mortality, skin diseases were the fourth leading cause of disability worldwide.

[1]  Cutaneous manifestations of systemic diseases. , 1955, Journal of the National Medical Association.

[2]  International Foundation of Dermatology , 1989, Journal of the American Academy of Dermatology.

[3]  D. Sackett,et al.  Cochrane Collaboration , 1994, BMJ.

[4]  D. Strachan,et al.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. , 1999, The Journal of allergy and clinical immunology.

[5]  D. Margolis,et al.  The incidence and prevalence of pressure ulcers among elderly patients in general medical practice. , 2002, Annals of epidemiology.

[6]  P. Heenan,et al.  A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. , 2011, Journal of the American Academy of Dermatology.

[7]  T. Dwyer,et al.  A temporal decline in asthma but not eczema prevalence from 2000 to 2005 at school entry in the Australian Capital Territory with further consideration of country of birth. , 2008, International journal of epidemiology.

[8]  E. Schernhammer,et al.  Time trends of the prevalence of asthma and allergic disease in Austrian children , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[9]  K. Hood,et al.  Excision of malignant melanomas in North Wales: effect of location and surgeon on time to diagnosis and quality of excision. , 2008, Family practice.

[10]  H. R. Anderson,et al.  Is eczema really on the increase worldwide? , 2008, The Journal of allergy and clinical immunology.

[11]  D. Strachan,et al.  The role of atopic sensitization in flexural eczema: findings from the International Study of Asthma and Allergies in Childhood Phase Two. , 2008, The Journal of allergy and clinical immunology.

[12]  K. Verhamme,et al.  Body mass index in Belgian schoolchildren and its relationship with sensitization and allergic symptoms , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[13]  H. Williams,et al.  How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two , 2009, The British journal of dermatology.

[14]  A. Burton,et al.  Association Between Asthma Symptoms and Obesity in Preschool (4-5 year old) Children , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[15]  F. De Baets,et al.  The association of allergic symptoms with sensitization to inhalant allergens in childhood , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[16]  K. Verhamme,et al.  The Prevalence, Characteristics of and Risk Factors for Eczema in Belgian Schoolchildren , 2009, Pediatric dermatology.

[17]  H. Williams,et al.  Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. , 2009, The Journal of allergy and clinical immunology.

[18]  A. Burton,et al.  Prevalence of Asthma Symptoms and Atopic Disorders in Preschool Children and the Trend over a Decade , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[19]  A. Ponsonby,et al.  The parent‐reported prevalence and management of peanut and nut allergy in school children in the Australian Capital Territory , 2009, Journal of paediatrics and child health.

[20]  D. Solé,et al.  Prevalence of symptoms of eczema in Latin America: results of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3. , 2010, Journal of investigational allergology & clinical immunology.

[21]  G. Haidinger,et al.  The prevalence of atopic dermatitis in children is influenced by their parents’ education: results of two cross‐sectional studies conducted in Upper Austria , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[22]  J. Zejda,et al.  Allergic diseases and respiratory symptoms in urban and rural children in Grodno Region (Belarus) , 2012, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[23]  A. Bernard,et al.  Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema. , 2012, Environmental research.

[24]  Alan D. Lopez,et al.  Measuring the global burden of disease. , 2013, The New England journal of medicine.

[25]  A. Ponsonby,et al.  The prevalence and socio‐demographic risk factors of clinical eczema in infancy: a population‐based observational study , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[27]  Mohsen Naghavi,et al.  GBD 2010: design, definitions, and metrics , 2012, The Lancet.

[28]  A seat at the big table: expanding the role of dermatology at the World Health Organization and beyond. , 2014, The Journal of investigative dermatology.

[29]  R. Hay,et al.  The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. , 2014, The Journal of investigative dermatology.

[30]  Amrapali Zaveri,et al.  Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. , 2014, JAMA dermatology.

[31]  J. Shiffman.  Knowledge, Moral Claims and the Exercise of Power in Global Health , 2014, International journal of health policy and management.

[32]  Nobhojit Roy,et al.  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition , 2015, The Lancet.

[33]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[34]  O. Ayo-Yusuf,et al.  Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa , 2015, Journal of skin cancer.

[35]  Mirjam Kretzschmar,et al.  Disability weights for the Global Burden of Disease 2013 study. , 2015, The Lancet. Global health.

[36]  I. Rudan,et al.  Global health metrics needs collaboration and competition , 2015, The Lancet.

[37]  M Augustin,et al.  The global challenge for skin health , 2015, The British journal of dermatology.

[38]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[39]  Dagmar Hartge,et al.  Report , 2019, Datenschutz und Datensicherheit - DuD.